Completion Nephrectomy Outcomes Following Prior Partial Nephrectomy in Hereditary Kidney Cancer Syndromes
Current Oncology · 06.08.2026 · 33 (8) · 468
DOI: 10.3390/curroncol33080468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 06.08.2026. Verfasst von Patrick D Michael und 8 weiteren Autor:innen. Beteiligte Einrichtung: Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Nephrectomy, Kidney Neoplasms, Neoplastic Syndromes, Hereditary. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural Research Program of the National Institutes of Health.
Abstract (Originalsprache)
Hereditary kidney cancer syndromes predispose patients to multifocal, bilateral and/or recurrent renal tumors, requiring repeated interventions over a lifetime. Despite nephron-sparing surgery being the preferred management strategy, some patients ultimately require completion nephrectomy—radical nephrectomy following prior ipsilateral partial nephrectomy—when tumor burden, declining renal function, surgical complications, or pre-transplant indications necessitate definitive kidney removal. Data on outcomes in this population remain limited. We evaluated a prospectively maintained cohort of 58 patients who underwent completion nephrectomy at the National Institutes of Health between 2000 and 2024, following at least one prior ipsilateral partial nephrectomy. Perioperative complication rates and renal functional change were the primary outcomes of interest. Von Hippel–Lindau disease was the most common hereditary diagnosis (62.1%). Open surgery was performed in 56.9% of cases. Overall complications occurred in 43.1% of patients, with 24.1% experiencing a Clavien–Dindo grade ≥ 3 event; perioperative mortality was 6.9%. The median preoperative estimated glomerular filtration rate was 72 mL/min/1.73 m2, declining to 50 mL/min/1.73 m2 at the first postoperative clinic visit. Completion nephrectomy in hereditary kidney cancer syndrome patients is associated with substantial perioperative morbidity, mortality, and expected renal functional decline. These findings inform patient counseling and surgical decision-making in this high-risk population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID-Profile: Patrick D Michael, Braden Millan, Sandeep Gurram, Mark W Ball
Förderung
- Intramural Research Program of the National Institutes of Health
Zitieren
APA
Michael, P. D., Loebach, L., Blachman-Braun, R., Fu, H., Millan, B., Saini, J., Gurram, S., Linehan, W. M., & Ball, M. W. (2026). Completion Nephrectomy Outcomes Following Prior Partial Nephrectomy in Hereditary Kidney Cancer Syndromes. Current Oncology, 33(8), 468. https://doi.org/10.3390/curroncol33080468
Vancouver
Michael PD, Loebach L, Blachman-Braun R, Fu H, Millan B, Saini J, et al. Completion Nephrectomy Outcomes Following Prior Partial Nephrectomy in Hereditary Kidney Cancer Syndromes. Current Oncology. 2026;33(8):468. doi:10.3390/curroncol33080468
BibTeX
@article{Michael2026,
author = {Michael, Patrick D and Loebach, Lauren and Blachman-Braun, Ruben and Fu, Hangcheng and Millan, Braden and Saini, Jaskirat and Gurram, Sandeep and Linehan, W Marston and Ball, Mark W},
title = {Completion Nephrectomy Outcomes Following Prior Partial Nephrectomy in Hereditary Kidney Cancer Syndromes},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {8},
pages = {468},
doi = {10.3390/curroncol33080468}
}
EUVIMED